Mirtazapine

Product NDC
57664-510
11-digit product format
576640510
Labeler code
57664
Product ID
57664-510_f5e842da-4922-4f1d-b2e0-a4c0be71e2a6
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Mirtazapine
Dosage form
TABLET
Route
ORAL
Labeler
Sun Pharmaceutical Industries, Inc.
Application
ANDA076541
Marketing category
ANDA
Marketing start
2004-04-22
Substance
MIRTAZAPINE
Active strength
7.5 mg/1
NDC exclude flag
No
Listing certified through
2026-12-31
Current FDA listing
Yes

Additional Listing Data#

Finished product
Yes
Brand name base
Mirtazapine
Listing expiration
2026-12-31

Active Ingredients#

Ingredient, Strength table
IngredientStrength
MIRTAZAPINE7.5 mg/1

Harmonized Identifiers#

Field, Values table
FieldValues
UniiA051Q2099Q
Rxcui311725, 311726, 314111, 476809

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
1ca5a24a-fafa-8fc8-52ac-b403ff18faa5Product name320240216
a733d273-402b-1005-9891-1ac1a9c63703Product name220170724

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
57664-510-83Mirtazapine30 in 1 BOTTLETABLET3011

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
57664-510-18EA - Each57664-510c77ba182-ac86-4b94-970f-c695f5809bc212013-02-13
57664-510-83EA - Each57664-510ec185781-b998-4411-aad7-d30cb941d15a12013-02-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIIDailyMed labelSPL versionUploaded
mirtazapineACTIVE INGREDIENTA051Q2099QMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
mirtazapineACTIVE MOIETYA051Q2099QMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
colloidal silicon dioxideINACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
corn starchINACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
hydroxypropyl celluloseINACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
hypromellose 2910INACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
iron oxide yellowINACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
iron oxides yellowINACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
lactose monohydrateINACTIVE INGREDIENTEWQ57Q8I5XMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
magnesium stearateINACTIVE INGREDIENT70097M6I30MIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
opadry 20A52767 (yellow colored film)INACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
opadry 20A56666 (reddish brown colored film)INACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
opadry 20A58916 (white colored film)INACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
pregelatinized starchINACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
red and blackINACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
titanium dioxdeINACTIVE INGREDIENTMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3
titanium dioxideINACTIVE INGREDIENT15FIX9V2JPMIRTAZAPINE (MIRTAZAPINE) TABLET [CARACO PHARMACEUTICAL LABORATORIES, LTD.]3

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
57664-510MIRTAZAPINE TABLET [SUN PHARMACEUTICAL INDUSTRIES, INC.]11Current NDC, Legacy NDC, 1 package rows20220126_f23631be-c7ae-46e9-b771-a70be17bc9f0.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
311725mirtazapine 15 MG Oral TabletPSNf23631be-c7ae-46e9-b771-a70be17bc9f011
314111mirtazapine 30 MG Oral TabletPSNf23631be-c7ae-46e9-b771-a70be17bc9f011
311726mirtazapine 45 MG Oral TabletPSNf23631be-c7ae-46e9-b771-a70be17bc9f011
476809mirtazapine 7.5 MG Oral TabletPSNf23631be-c7ae-46e9-b771-a70be17bc9f011
311725mirtazapine 15 MG Oral TabletSCDf23631be-c7ae-46e9-b771-a70be17bc9f011
314111mirtazapine 30 MG Oral TabletSCDf23631be-c7ae-46e9-b771-a70be17bc9f011
311726mirtazapine 45 MG Oral TabletSCDf23631be-c7ae-46e9-b771-a70be17bc9f011
476809mirtazapine 7.5 MG Oral TabletSCDf23631be-c7ae-46e9-b771-a70be17bc9f011
476809mirtazapine 7.5 MG Oral TabletPSNe5478a6a-a29a-9f61-e053-2995a90a11d03
476809mirtazapine 7.5 MG Oral TabletSCDe5478a6a-a29a-9f61-e053-2995a90a11d03

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
57664-510-835766405108330 TABLET in 1 BOTTLE (57664-510-83) 30 tablet2004-04-220000-00-00NoNoCurrent